Recent findings for COVID-19 testing, including the recently published Summary of Current Evidence, suggest that testing of lower respiratory samples of the lungs of potential donors may likely decrease the risk of unrecognized infection.
This resource lists tests authorized by the Food and Drug Administration to analyze lower respiratory tract specimens. Organ procurement organizations can use the list to locate laboratories performing these tests or to help their laboratory services gain access to them.
